Adverse events of treatment with rituximab in patients with myositis

Rheumatology (Oxford). 2023 Feb 1;62(2):e16-e17. doi: 10.1093/rheumatology/keac398.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antirheumatic Agents* / adverse effects
  • Humans
  • Myositis* / chemically induced
  • Myositis* / drug therapy
  • Rituximab / adverse effects
  • Treatment Outcome

Substances

  • Rituximab
  • Antirheumatic Agents